Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trialMariaelena Pierobon, Stephen P. Anthony, Shukmei Wong et al.|Molecular Oncology|2021Cited by 14
Author response for "Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial"Mariaelena Pierobon, Stephen P. Anthony, Nicholas J. Robert et al.|Unknown|2021Cited by 0